凡临床试验都应在中国临床试验注册中心注册

发布时间：2018-08-27 08:50

【摘要】：正全球临床试验注册制度由世界各国政府共同决定由WHO领导建立。临床试验注册具有伦理和科学的双重意义,目的是为了尊重和珍惜所有试验参与者的贡献,他们的贡献用于改善全社会的医疗保健,因此,任何临床试验都与公众利益相关。公开临床试验的信息,并将其置于公众监督之下是试验研究者的义务和道德责任。临床试验注册不仅能确保追溯每个临床试验的结果,公开在研试验或试验结果信息还有助于减少不必要的重复研究。
[Abstract]:The global clinical trial registration system is jointly decided by governments around the world and led by WHO. Clinical trial registration is of both ethical and scientific significance in order to respect and value the contributions of all participants, whose contributions are used to improve health care throughout society. Therefore, any clinical trial is in the public interest. It is the duty and moral responsibility of the trial researchers to make public information about clinical trials and place them under public supervision. Clinical trial registration not only ensures that the results of each clinical trial are traced, but that disclosure of information on the results of ongoing trials or trials also helps to reduce unnecessary duplication of research.
【分类号】：+

【相似文献】